ANNOUNCING
Sherlock Biosciences Acquires Sense Biodetection Advancing CRISPR-based Diagnostics for Consumers
Read More
The future of diagnostic testing is here – and anywhere you need it.*
Speed, accuracy and mobility are more important than ever when it comes to molecular diagnostics. At Sense, our vision is to deliver it all – everywhere.
Available Now!Discover Veros COVID-19 |
 |
*Available in select EU markets.
For Hospitals
Ensure fast, lab-quality results – without central lab delays.
For Urgent Care
Provide confident results to patients in about 15 minutes.
For Nursing Homes
Make ongoing testing easier with a truly instrument-free, portable and disposable testing platform.
¹ Prospective, multicentre study of 292 evaluable subjects conducted during Delta and Omicron variant surges. Veros COVID-19 results were compared directly against a highly-sensitive, state-of-the-art, CE Marked qRT-PCR test. Data on file.
Sense
Transforming
healthcare by
redefining
diagnosticsâ„¢
Right now, there’s an opportunity to bring quality care to more people in more places* than ever before. At Sense, we’re seizing that opportunity – and putting it right in caregivers’ hands.
*Available in select EU markets.
